Accelerating Bold and Innovative Ideas in #RadOnc
ROI Research Results at the Annual Meeting
Sunday, September 29
4:45 p.m. | Poster Q&A 02 - Physics
2451: Feasibility of Cardiac Chamber Auto-Segmentation and Dose Optimization for MR-Guided Online Adaptive Radiotherapy of Central Lung Cancer
Monday, September 30
8:00 a.m. | Poster Q&A 03 - Gynecological Cancer, Pediatric Cancer, and Professional Development
3574: Evaluation of a Graphic Narrative Patient Education Tool to Reduce Pre-Treatment Anxiety for Patients Receiving Radiotherapy in a Latin American Hospital
3:00 p.m. | SS 23 - Patient Safety 1: Using Yesterday’s Data to Drive Tomorrow’s Change: Advances in Patient Safety
236: “If You’re Talking, I Think You’re Muted:” Follow-Up Analysis of Weekly Peer Review Discussion and Deviation Detection after Transitioning from Virtual to In-Person Format
Tuesday, October 1
12:45 p.m. | Poster Q&A 07 - Gastrointestinal Cancer and Sarcoma/Cutaneous Tumors
3066:Safety and Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients with Advanced Cirrhosis Awaiting Liver Transplantation: An ROI-funded Prospective Pilot Study
4:00 p.m. | Poster Q&A 09 - Hematologic Malignancies and Digital Health Innovations
3395:A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery: A Randomized Trial
5:15 p.m. | Poster Q&A 08 - Gynecological Cancer, Pediatric Cancer and Professional Development
Pilot Study Assessing Student Interest in Combined Residency Training Pathways with Radiation Oncology
Wednesday, October 2
10:30 a.m. | Poster Q&A 10 - Head & Neck Cancer and Health Services Research/Global Oncology
3606:Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapy’s Environmental Load?
3620:Parotid Voxel Dose Analysis with Machine Learning Toward Xerostomia Prediction in Head and Neck Cancer Irradiation
3722:Evaluating the Impact of Wildfires on Radiotherapy Compliance and Financial Costs: Insights from a Multi-Clinic Analysis
With support from 2,500+ donors, the Radiation Oncology Institute (ROI) — the charity foundation for ASTRO — has accelerated bold and innovative ideas in radiation oncology by funding more than $4.7 million in research projects to help every person have access to the best radiation oncology to live a longer, healthier life.
ROInstitute.org | @RO_Institute
ROI Research: Accelerating the Safe Delivery of Proton FLASH RT
ROI Researcher Joseph Harms, PhD, is leading the development of a new detector to accurately and repeatably measure the intense radiation fields delivered during proton FLASH radiation therapy. The innovative system is a critical advance toward safely treating patients with FLASH in the clinic.The detector combines a high-speed camera and a scintillator, a material that emits light when exposed to radiation, to provide real-time verification of the dose and dose rate during treatment. See Dr. Harms’ colleague Megan Clark, a Medical Physics PhD student at Dartmouth, present key results about how the system detects errors in the delivery of realistic patient treatment plans in a pre-clinical setting for FLASH RT during the “Best of Physics” session on Wednesday, October 2 at 11:00 a.m. in Room 145.
